Active ingredient: Hyaluronic acid sodium salt (Hyalectin) 20 mg.
Excipients/Inactive Ingredients: Sodium chloride, Monobasic sodium phosphate dihydrate, Dibasic sodium phosphate dodecahydrate, Water for injections q.s. to 2 ml.
The intra-articular administration of Hyalgan into arthritic joints improves pain and joint function possibly due to the normalization of synovial fluid viscoelasticity and due to its interaction with synoviocytes and chondrocytes.
For the treatment of pain in osteoarthritis of the knee.
2 ml of HYALGAN (20 mg) administered intra-articularly once a week for 5 weeks or as directed by the physician.
Hyalectin, the active principle in Hyalgan, is of avian origin. Do not administer to patients with known hypersensitivity to any ingredient of the product or to avian proteins. Intra-articular injections are contraindicated in cases of infections or skin diseases in the area of the injection site.
It is necessary to follow a correct technique of intra-articular injection in accurately aseptic conditions.
HYALGAN is generally well tolerated. However, in rare cases, some patients have exhibited a transient and moderate pain symptomatology.
In any case, all suspected adverse reactions occurring during the treatment with HYALGAN should be reported to the physician.
Incompatibilities: There are currently insufficient data to support the compatibility of HYALGAN with other drugs administered intra-articularly. Therefore the mixing or simultaneous administration with other intra-articular drugs is not recommended.
Discard unused portion: After use, dispose according to applicable national practice.
M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.
Hyalgan inj 10 mg/mL
2 mL x 1's